Corrections to the Funding/Support Statement and Conflict of Interest Disclosures
-
October 8, 2026
Clinical Scorecard: Corrections to the Funding/Support Statement and Conflict of Interest Disclosures
At a Glance
| Category | Detail |
|---|---|
| Condition | Periprocedural mortality risk after elective atrial fibrillation ablation |
| Key Mechanisms | Not described in the correction notice. |
| Target Population | Not specified in the correction notice. |
| Care Setting | Not specified in the correction notice; it corrects disclosures in an original investigation. |
Key Highlights
- A correction was issued for the original investigation “Periprocedural Mortality Risk After Elective Atrial Fibrillation Ablation in Japan,” which appeared on August 29, 2026.
- The Funding/Support statement contained an incorrect grant identifier.
- The Conflict of Interest section contained a typographical mistake.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Not specified in the correction notice.
The notice concerns corrections to funding and conflict-of-interest disclosures, not treatment.
Clinical Best Practices
Related Resources & Content
Based on findings from:
Errors in Funding/Support Statement and Conflict of Interest Disclosures
Jama Network Open, 2026.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2854977
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
